25 May 2023
BRAIN Biotech AG publishes half year report with strong results remaining on solid growth path
Parent company, BRAIN Biotech AG today published its half year results, 6M 2022/2023, remaining on track to deliver on its full year financial targets and accelerates exciting growth strategy.
24 May 2023
BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
BRAIN Biotech AG has bought the two remaining minority stakes in Biocatalysts Ltd, Wales. Biocatalysts is now fully owned by BRAIN Biotech AG, the parent company of the BRAIN Biotech Group, and will form the nucleus of the Group’s ambitious growth strategy to create a global multi-niche enzyme champion.
16 May 2023
The Role of Nuclease 46L in Degrading Nucleic Acids
Nucleic acids are fundamental in many industrial biotechnology processes. However, its presence can be undesirable in certain applications. Removal of any contaminating residual nucleic acids can reduce these impurities and result in a higher quality end product.
We're exhibiting at IFT First in Chicago
Join us on the 17th - 19th of July in Chicago for IFT First's annual event and expo
1 May 2023
Bromelain: Powerful proteolytic enzyme
The unique combination of proteolytic activities makes Bromelain a real workhorse enzyme across numerous industries, from dairy protein hydrolysates and meat tenderisation in the food industry, to beer clarification and even pharmaceutical and dietary supplements.
27 Mar 2023
Biocatalysts Ltd Finalists for Wales Business Award
We're proud to announce that we've been shortlisted by Wales Business Awards for the category 'Global Business of the Year'.
2 Mar 2023
Biocatalysts Ltd launch Nuclease for the growing precision fermentation market
Nuclease 46L has been designed specifically as a cost-effective solution for the elimination of nucleic acids in a wide range of biotechnology applications.
27 Feb 2023
BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion
With the enzyme activities of the group focusing on food, beverage and healthcare, combined with BRAIN Biotech's strong scientific roots, the Group are well positioned to service global megatrends from the production of better and healthier foods to sustainable industrialisation.
16 Jan 2023
BRAIN Biotech AG reports record figures in fiscal year 2021/22
Despite a challenging geopolitical environment, BRAIN Biotech announce strong sales laying the foundations for ongoing future dynamic growth.
18 Nov 2022
Biocatalysts awarded in Top 10 Synthetic Biology Companies 2022 by Life Sciences Review!
We're very pleased to receive this esteemed award from Life Sciences Review in their annual listing of 10 companies that are at the forefront of providing Synthetic Biology solutions and transforming businesses.
Improving Emulsifying Properties of Eggs
Eggs are a valuable food source providing a natural source of many nutrients including high quality protein, vitamins and minerals, that are essential for healthy body growth and development.
Enzymes for Superior Palatability of Pet Food
Combinations of proteases and lipases can be used to hydrolyse meat by-products and plant-based proteins to produce palatants. Palatants are flavours specifically produced by enzymically breaking down animal fats and proteins to give a sensory boost to pet food.